Alternatives to EviCure

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.